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Main*points:*
• Magnetic"resonance"imaging"provides"means"to"evaluate"response"to"IL=13"therapy."
• IL=13"immune"gene"therapy"protects"against"cuprizone=induced"demyelination."
• IL=13"immune"gene"therapy"induces"alternative"activation"of"microglia"and"macrophages."
"
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ABSTRACT"
"
Detrimental" inflammatory" responses" in" the" central"nervous" system"are"a"hallmark"of" various"brain"
injuries"and"diseases."With"this"study"we"provide"evidence"that"lentiviral"vector=mediated"expression"
of"the"immune=modulating"cytokine"interleukin"13"(IL=13)"induces"an"alternative"activation"program"
in" both"microglia" and"macrophages" conferring" protection" against" severe" oligodendrocyte" loss" and"
demyelination" in" the" cuprizone" mouse" model" for" multiple" sclerosis" (MS)." First," IL=13" mediated"
modulation" of" cuprizone=induced" lesions" was" monitored" using" T2=weighted" magnetic" resonance"
imaging" and" magnetization" transfer" imaging," and" further" correlated" with" quantitative" histological"
analyses"for"inflammatory"cell"influx,"oligodendrocyte"death"and"demyelination."Second,"following"IL=
13" immune" gene" therapy" in" cuprizone=treated" eGFP+" bone" marrow" chimeric" mice," we" provide"
evidence" that" IL=13" directs" the" polarization" of" both" brain=resident" microglia" and" infiltrating"
macrophages"towards"an"alternatively"activated"phenotype,"thereby"promoting"the"conversion"of"a"
pro=inflammatory"environment"towards"an"anti=inflammatory"environment,"as"further"evidenced"by"
gene"expression"analyses."Finally,"we"show"that"IL=13"immune"gene"therapy"is"also"able"to"limit"lesion"
severity" in" a" pre=existing" inflammatory" environment." In" conclusion," these" results" highlight" the"
potential"of"IL=13"to"modulate"microglia/macrophage"responses"and"to"improve"disease"outcome"in"a"
mouse"model"for"MS."
*
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INTRODUCTION*
"
While" innate" immune" cells" of" the" central" nervous" system" (CNS)" at" one" hand" play" a"major" role" in"
development"and"maintenance"of"brain"integrity"and"function"(Kettenmann"et"al."2011;"Nimmerjahn"
et"al."2005;"Ransohoff"and"Perry"2009),"dysregulation"of"CNS"immune"responses"on"the"other"hand"is"
highly"associated"with"the"pathophysiology"of"various"neurodegenerative"diseases"(Perry"et"al."2010;"
Prinz"et"al."2011)," including"demyelinating"disorders" like"multiple"sclerosis" (MS)" (Lassmann"and"van"
Horssen"2015;"Mahad"et"al."2015;"Rawji"and"Yong"2013;"Sriram"2011)."Microglia,"well=recognized"as"
brain" tissue=specific" macrophages" (Chan" et" al." 2007;" Ginhoux" et" al." 2010;" Ginhoux" et" al." 2013;"
Tambuyzer"et"al."2009),"have"the"unique"capacity"to"sense"alterations"of"the"brain"microenvironment,"
and"in"response"rapidly"migrate,"proliferate"and"undergo"specific"differentiation"programs"in"order"to"
restore" brain" homeostasis" (Ousman" and" Kubes" 2012)." Functionally" differentiated" microglia" and"
macrophages" are" commonly" subdivided" in" two" categories" (Martinez" and"Gordon" 2014;"Mills" et" al."
2000;"Mosser"and"Edwards"2008;"Murray"et"al."2014)," the"classically"activated"phenotype,"which" is"
characterized" by" the" secretion" of" pro=inflammatory" and" cytotoxic"mediators," and" the" alternatively"
activated"phenotype,"which"generally"contributes"to"extracellular"matrix"remodelling,"progenitor"cell"
differentiation"and"tissue"regeneration."Experimental"modulation"of"these"microglia"and"macrophage"
polarization"states"can"easily"be"achieved"in#vitro"through"supplementation"of"microglia/macrophage"
cultures"with"lipopolysaccharides"(LPS)"and"interferon"gamma"(IFN=ϒ)"or"with"interleukin"(IL)=4/13"to"
induce"the"classically"activated"or"the"alternatively"activated"polarization"state,"respectively"(Gordon"
2003;"Mills"et"al."2000)."In"this"study,"our"main"aim"is"to"investigate"whether"targeted"in#vivo"delivery"
of" IL=13" at" the" onset" of," or" during" neuro=inflammatory" processes," can" alter" degenerative" (histo=
)pathological"disease"outcomes.""
"
Activated"microglia"and"macrophages"are"suggested"to"co=orchestrate"oligodendrocyte"death"in"the"
cuprizone"mouse"model"of"CNS"demyelination"(Hiremath"et"al."1998;"Kipp"et"al."2009;"Matsushima"
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and" Morell" 2001;" Praet" et" al." 2014a)." In" this" study" we" applied" lentiviral" vector" (LV)=mediated"
transduction"of"the"splenium"of"the"corpus"callosum"(CC),"i.e."the"brain"area"affected"most"prominent"
in" this" neuro=inflammation"mouse"model," in" order" to" investigate" the" effect" of" IL=13"on"developing"
neuro=inflammatory" lesions" and" subsequent" demyelinating" events."While" recent" in# vivo" treatment"
strategies" aiming" at" directing" the" differentiation" of" microglia" and" macrophages" towards" an"
alternatively"activated"state"highly"rely"on"histological"analyses"to"demonstrate"reduced"CNS"damage"
and"improved"disease"outcome"(Hu"et"al."2012;"Ma"et"al."2015;"Miron"et"al."2013;"Yang"et"al."2015),"
we"here"additionally"performed"magnetic"resonance" imaging"(MRI)"as"the"gold"standard"for" in#vivo"
detection"of"demyelinating"lesions"in"CNS"white"matter"(Polman"et"al."2011;"Trip"and"Miller"2005)."In"
addition" to" standard"T2=weighted"MRI,"we"also"utilized"magnetization" transfer" imaging" (MTI)" as" an"
emerging" technique" to" provide" greater" insight" into" the" tissue" microstructure" in" terms" of"
inflammation," gliosis" and" myelination" (Ropele" and" Fazekas" 2009)." Hence," we" here" report" on"
multiparametric" MRI" approaches" complementary" and" correlating" to" our" quantitative" histological"
analyses" for" an" accurate" in# vivo"monitoring" of" CNS" inflammatory" and" demyelinating" pathology," as"
well"as"the"effect"of"IL=13"immune"gene"therapy"thereon."Finally,"as"one"of"the"major"unsolved"issues"
in" CNS" neuro=de/regeneration" relates" to" the" specific" roles" for" CNS=resident" microglia" and" CNS=
invading"peripheral"macrophages"(London"et"al."2013)," in"our"experimental"setup"using"eGFP+"bone"
marrow" chimeric" mice" we" attempted" to" clarify" potential" different" and" specific" roles" of" both"
populations"in"disease"and"during"IL=13"LV=mediated"immune"gene"therapy"in"the"CNS."
"
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MATERIALS*AND*METHODS*
*
Mice*
C57BL/6J=Tyrc,2J/J" mice" (albino" C57BL/6J" mice," strain" code" 000058)" and" transgenic" C57BL/6=eGFP"
mice"(strain"code"003291)"were"obtained"via"Jackson"Laboratories"and"bred"in"the"animal"facility"of"
the"University" of" Antwerp." For" all" experiments,"mice"were" kept" in" normal" day–night" cycle" (12/12)"
with"ad#libitum"access"to"food"and"water."All"experimental"procedures"were"approved"by"the"Ethics"
Committee"for"Animal"Experiments"of"the"University"of"Antwerp"(Approval"No"2011/13)."
*
The*cuprizone*mouse*model*
At" the"age"of"eight"weeks,"mice" received"a" standard" rodent"chow"mixed"with"0.2%"w/w"cuprizone"
(Sigma=Aldrich)" for" a" period" of" 4" weeks" in" order" to" induce" neuro=inflammation" and" CNS"
demyelination,"as"previously"described"(Guglielmetti"et"al."2014;"Orije"et"al."2015;"Praet"et"al."2015a;"
Praet"et"al."2012)."
"
Lentiviral*vector*construction*and*production*
The" pCHMWS=IL=13=IRES=Pac" lentiviral" vector" (LV)" plasmid" was" constructed" by" replacing" the" eGFP"
cDNA" insert" (SpeI/XbaI" digest)" from" the" pCHMWS=eGFP=IRES=Pac" plasmid" (provided" by" the" Leuven"
viral" vector" core," Molmed," KULeuven," Belgium)" with" the" IL=13" cDNA" (NcoI/NheI" digest)" from" the"
pORF=mIL=13"plasmid"(InvivoGen)"using"standard"subcloning"techniques."The"pCHMWS=BFP=IRES=Pac"
plasmid"was" constructed"by" replacing" the"eGFP"cDNA" insert" (SpeI/XbaI"digest)" from" the"pCHMWS=
eGFP=IRES=Pac"plasmid"with"the"BFP"cDNA"(SmaI/XbaI"digest)"from"the"TagBFP"plasmid"(Evrogen)"(Le"
Blon"et"al."2014)."The"pCHMWS=IL=4=IRES=Pac"plasmid"was"constructed"by"replacing"the"eGFP"cDNA"
insert" (SpeI/XbaI" digest)" from" the" pCHMWS=eGFP=IRES=Pac" plasmid"with" the" IL=4" cDNA" (NcoI/NheI"
digest)" from" the" pORF=mIL=4" plasmid" (InvivoGen)." Before" proceeding" to" LV" production," all" three"
plasmids"were"electroporated"in"K562"cells"followed"by"stable"selection"by"addition"of"puromycin"to"
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the" culture"medium." Expression"of" IL=13"or" IL=4"was" confirmed"by" a"murine" IL=13"or" a"murine" IL=4"
ELISA" (Peprotech)," respectively." Expression" of" the" BFP" reporter" protein" was" confirmed" by" flow"
cytometric" analysis." Following" confirmation" of" IL=13," IL=4" and" BFP" expression," LV" production" was"
outsourced"to"the"Leuven"viral"vector"core,"as"previously"described"(Baekelandt"et"al."2003;"Geraerts"
et"al."2005)."
*
Stereotaxic*injections*of*lentiviral*vector*
All" surgical" interventions" were" performed" according" to" institutional" guidelines." Briefly," mice" were"
anesthetized" by" intraperitoneal" (IP)" injection" of" a" ketamine" (75"mg/kg," Anesketin;" Eurovet"
NV/SA)"+"medetomidine" (1"mg/kg," Domitor;" Pfizer" Animal"Health" S.A.)"mixture" and" positioned" in" a"
stereotactic"head" frame" to"achieve" flat" skull"position" (Stoelting)." Stereotactic" coordinates" to" target"
the"splenium"of"the"CC"were"as"follows:"AP"=1.6"mm,"Lat"0.3"mm"and"DV"=1.1"mm"(relative"to"bregma,"
Figure"1a)."A"midline"scalp"incision"was"made"to"expose"the"skull,"and"a"hole"was"drilled"in"the"skull"
using"a"dental"drill"burr"(Stoelting)."Thereafter,"an"automatic"micro=injector"pump"(kdScientific)"with"
a" 10"μl" Hamilton" syringe" was" positioned" above" the" exposed" dura." A" 32=gauge" needle" (Hamilton),"
attached"to"the"syringe,"was"placed"through"the"intact"dura"and"positioned"at"the"respective"depth."
After"2"min"of"pressure"equilibration,"2"μl"of"LV"concentrate"(1.5x107=3x107"pg/ml"p24)"was"injected"
at"a"speed"of"0.5"μl/min."Before"final"needle"retraction,"a"waiting"period"of"5"min"was"kept"in"order"to"
allow"for"pressure"equilibration"and"to"prevent"backflow"of"the"injected"LV"suspension."Next,"the"skin"
was"sutured"(Vicryl,"Ethicon)"and"a"0.9%"NaCl"(Baxter)"solution"was"given"subcutaneously"in"order"to"
prevent" dehydration" while" mice" were" placed" under" a" heating" lamp" to" recover." Anesthesia" was"
reversed"by"an"IP"injection"of"atipamezol"(Antisedan"5"mg/ml,"Pfizer"Animal"Health"S.A.)."
*
Bone*marrow*transplantation*
In"order" to"discriminate"microglia"and"macrophages,"eGFP+"bone"marrow"(BM)"chimeric"mice"were"
generated"as"previously"described"(Le"Blon"et"al."2014)."Briefly,"four"to"six"weeks"old"mice"received"
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10Gy"total"body" irradiation"using"an"XRAD320"small"animal" irradiation"device"(Precision"X=Ray)."For"
this,"groups"of"five"non=anesthetised"mice"were"placed"in"a"single"cage"within"the"whole"irradiation"
field"(without"head"protection)."Next,"a"single"intravenous"injection"of"total"eGFP+"BM"cells"(1.5x106"
cells"in"100µl"PBS)"was"administered"via"the"tail"vein"within"6"hours"post=irradiation."Total"eGFP+"BM"
cells"were"isolated"from"8=week"old"C57BL/6=eGFP"mice"by"flushing"dissected"femurs"and"tibias"with"
sterile" PBS." Before" administration," total" BM" cells"were" filtered" over" a" 70" µm" sterile"mesh" (Becton"
Dickinson),"centrifuged"and"suspended"in"PBS."During"recovery,"mice"were"treated"with"Enrofloxacin"
(1µl/mL;"Baytril"10%;"Bayer)"added"to"the"drinking"water"for"4"weeks"post=irradiation."
"
Magnetic*resonance*imaging*acquisition*
In#vivo# imaging"experiments"were"conducted"at"400"MHz"on"a"9.4T"Bruker"Biospec"system"(Biospec"
94/20"USR,"Bruker"Biospin)"using"a"standard"Bruker"cross"coil"setup,"with"a"quadrature"volume"coil"
for" excitation" and" quadrature"mouse" surface" coil" for" signal" detection." During" imaging," mice" were"
anesthetized"using"2%" isoflurane"(Isoflo®,"Abbot"Laboratories"Ltd.)" in"a"mixture"of"30%"O2"and"70%"
N2O"at"a"flow"rate"of"600"ml/min."Mice"were"fixed"in"an"animal"restrainer"with"ear"bars"and"a"tooth"
bar." Respiratory" rate" was" continuously" monitored" and" body" temperature" was" measured" and"
maintained"constant"at"37°C"using"a"feedback"coupled"warm"air"system"(MR"compatible"Small"Animal"
Monitoring"and"Gating"System,"SA"instruments,"Inc.)."First,"anatomical"RARE=T2"images"were"acquired"
to"determine"the"position"of"the"mouse"in"the"magnet"and"enable"a"uniform"position"of"the"coronal"
slices"for"every"T2"and"MTI"experiments"(repetition"time"(TR)"="2500"ms;"echo"time"(TE"[effective])"="
33.44"ms;"RARE"factor"="8;"number"of"slices"(NS)"="16"with"a"slice"thickness"of"0.4"mm;"field"of"view"
(FOV)"="20"x"20"mm;"matrix"size"="256"x"256;"in=plane"resolution"of"0.078"x"0.078"mm;"scan"time"="1"
min"20"seconds)."T2"values"were"acquired"with"the"Multi=Slice,"Multi=Echo"(MSME)"sequence"that" is"
based"on"the"Carr=Purcell=Meiboom=Gill"(CPMG)"sequence,"where"transverse"magnetization"of"a"90°"
pulse" is" refocused" by" a" train" of" 180°" pulses" generating" a" series" of" echoes." The" following" imaging"
parameters"were"used:"number"of"averages"(NA)"="1;"NS="6"with"a"slice"thickness"of"0.4"mm"and"an"
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interslice"thickness"of"0.4"mm;"number"of"echoes"="10"with"echo"spacing"="8.5"ms"(TE)"being"8.5;"17;"
25.5;"34;"42.5;"51;"59.5;"68;"76.5;"85);"TR"="4000"ms;"FOV"="20"x"20"mm;"matrix"size"="256"x"256;""in=
plane" resolution"=" 0.078" x" 0.078"mm," scan" time"=" 12"min"48" seconds)." For"magnetization" transfer"
contrast" (MTC)" MRI," an" off=resonance" RF" pulse" was" incorporated" into" a" RARE" T2" sequence"
(TR"="4100"ms," TE"[effective]="33.44" ms;" RARE" factor" =" 8;" NS" =" 1" with" a" slice" thickness" of" 1" mm,"
FOV"="20"×"20"mm,"matrix" size"="192"×"192," in=plane" resolution" of" 0.104" x" 0.104"mm," NA"=" 3," scan"
time" " =" 4" min" 55" seconds)." RARE" T2" images" were" acquired" without" off=resonance" RF" pulse"
(unsaturated)" and" with" off=resonance" RF" pulse" (saturated)" applied" (pulse" strength"="3"μT;" pulse"
length"="4000"ms," saturation" time"="0.244"ms)" at" the" offset" frequency" of" 2000" Hz." MTC" MRI" was"
acquired"at"two"different"location"of"the"mouse"brain,"first"at"the"level"of"the"splenium"of"the"CC,"and"
second"at"the"level"of"the"external"capsule."
*
Magnetic*resonance*imaging*processing*
T2" maps" were" generated" with" custom=built" programs" written" in" MATLAB" (MATLAB" R2011b," The"
MathWorks"Inc.)"using"a"monoexponential"fit"function"[y="A+C*exp"(=t/T2)],"where"A"="Absolute"bias,"
C"="signal"intensity,"T2"="transverse"relaxation"time."Regions"of"interest"(ROIs)"were"drawn"manually"
on" the" T2=weighted" images" (Figure" 1b)," according" to" a" mouse" brain" atlas," with" AMIRA" software"
(Mercury" Computer" systems)" and" regional" average" T2" values" were" calculated." ROIs" included" the"
external"capsule"and"the"splenium"of"the"CC."For"MTI"experiments,"saturated"images"were"realigned"
to"the"unsaturated"image"using"AMIRA,"for"each"animal"separately."The"realigned"images"were"used"
to"calculate"magnetization"transfer"ratio"(MTR)"="(unsaturated"−"saturated)"/"unsaturated)."ROIs"were"
manually" delineated" on" the" MTR" images" (Figure" 1b)" and" the" mean" MTR" were" calculated" for" the"
external"capsule"and"the"splenium"of"the"CC."
"
Immunofluorescence*analysis*
11"
"
All" immunofluorescence" analyses" were" performed" according" to" previously" described" procedures"
(Praet" et" al." 2014b;" Reekmans" et" al." 2013)." Mice" were" first" perfused" with" an" ice" cold" 0.9%" NaCl"
solution" followed"by" an" ice" cold" 4%"paraformaldehyde" (PFA)" solution."Next," brains"were"dissected"
and"further" fixated" in"4%"PFA"for"2h," then"dehydrated"through"a"sucrose"gradient" (2h"at"5%,"2h"at"
10%"and"overnight"at"20%)."Afterwards,"brain"tissue"was"snap=frozen"in"liquid"nitrogen"and"kept"at"=
80°C" until" further" processing." Ten" µm=thick" cryosections" were" collected" using" a" microm" cryostat."
Immunofluorescence" staining" was" performed" on" brain" slides" using" the" following" antibody"
combinations:" a" primary" chicken" anti=MBP" antibody" (Millipore," AB9348;" 1:200" dilution)" with" a"
secondary" donkey" anti=chicken" dylight" 549" antibody" (Jackson," 703=506=155," 1:1000" dilution);" a"
primary" rabbit" anti=GFAP" antibody" (Abcam," ab7779," 1:500" dilution)"with" a" secondary" donkey" anti=
rabbit" Alexa" Fluor" 555" antibody" (Invitrogen," A31572," 1:1000" dilution);" a" mouse" anti=APC/CC1"
antibody"(Calbiochem,"OP80;"1:100"dilution)"in"combination"with"a"goat"anti=mouse"Alexa"Fluor"555"
antibody" (Invitrogen," AF21425;" 1:1000" dilution);" a" primary" rat" anti=F4/80" antibody" (AbD" serotec,"
MCA497R,"1:250"dilution)"with"a"secondary"goat"anti=rat"Alexa"Fluor"555"(Invitrogen,"A21434,"1:200"
dilution);" a" primary" rabbit" anti=Iba1" antibody" (Wako," 01919741," 1:500" dilution)" with" a" secondary"
donkey" anti=rabbit" AF555" (Invitrogen," A31572," 1:1000" dilution);" a" primary" rat" anti=mouse" CD11b"
antibody" (Immunotools," 22159111," 1:200" dilution)" with" a" secondary" goat" anti=rat" Alexa" Fluor" 555"
(Invitrogen," A21434," 1:200" dilution);" a" primary" rat" anti=MHCII" antibody" (eBioscience," 14=5321=82,"
1:200"dilution)"with"a" secondary"goat" anti=rat"Alexa"Fluor"350"antibody" (Invitrogen,"A21093,"1:200"
dilution);"a"primary"rat"anti=MHCII"biotinylated"antibody"(eBioscience,"13=5321=85,"1:200"dilution)"in"
combination"with" a" streptavidin=Cy5" conjugate" (Invitrogen," SA1011," 1:50" dilution);" a" primary" goat"
anti=Arg=1" antibody" (Santa" Cruz," sc=18354," 1:50" dilution)"with" a" secondary" donkey" anti=goat" Alexa"
Fluor" 555" (Invitrogen," A21432," 1:200" dilution)" or" donkey" anti=goat" Alexa" Fluor" 350" (Invitrogen,"
A21081," 1:200" dilution)." Slides" were" counterstained" using" TOPRO=3" (Invitrogen," T3605," 1:200"
dilution)"or"DAPI" (Sigma,"1:1000"dilution)."Following"staining,"sections"were"mounted"using"Prolong"
Gold"Antifade"(Invitrogen,"P36930)."Fluorescence"image"acquisition"was"performed"using"a"standard"
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research" fluorescence" microscope" (Olympus" Bx51" fluorescence" microscope)" equipped" with" an"
Olympus" DP71" digital" camera." Olympus" cellSense" Software" (v" 1.4)" was" used" for" wide" field" image"
acquisition."
"
Histological*quantification*
Quantitative"analyses"of"macrophage"and/or"microglia"responses"were"performed"using"TissueQuest"
immunofluorescence" analysis" software" (TissueGnostics"GmbH," v3.0)," as" previously" described" by" us"
(De"Vocht"et"al."2013;"Le"Blon"et"al."2014;"Praet"et"al."2015b;"Reekmans"et"al."2013)."The"following"
parameters" were" determined:" the" cellular" density" of" F4/80+" microglia/macrophages," the" cellular"
density"of"Arg=1+"microglia/macrophages,"the"cellular"density"of"MHCII+"microglia/macrophages"and"
the" cellular" density" of" eGFP+" macrophages," Additionally," the" cellular" density" of" CC=1+"
oligodendrocytes" was" determined" using" the" same" software." Using" NIH" ImageJ" analysis" software"
(v1.46r),"the"degree"of"glial"fibrillary"acidic"protein"(GFAP)"astrogliosis"and"myelin"basic"protein"(MBP)"
was"determined"based"on"the"image=covering"staining"and"expressed"as"percentage"of"the"total"area,"
as"previously"described"by"us"(Praet"et"al."2015a)."
"
qRT7PCR*
Mice"were"perfused"with"ice=cold"0.9%"NaCl"solution,"directly"followed"by"removal"of"the"brain"and"
dissection"of"the"CC"area"around"the" injection"site."The"extracted"tissue"sections"were" immediately"
placed"in"RNALater"solution"(Ambion)"and"following"overnight"incubation"at"4°C"stored"at"=20°C"until"
further" processing." Total" RNA"was" extracted" using" the" Purelink" RNA"Kit" (Invitrogen)." RNA"quantity"
and" purity"were" determined" using" a"ND=1000"micro=spectrophotometer" (NanoDrop" Technologies)."
One=μg"total"RNA"was"reverse=transcribed"using"a"mixture"of" random"primers" (High"Capacity"cDNA"
Reverse" Transcription" kit," Applied" Biosystems)." PCR" primers" (provided" in" Supplementary" Table" S1)"
were" designed" with" Primer3" software" to" bridge" the" exon–intron" boundaries" within" the" gene" of"
interest"to"exclude"amplification"of"contaminating"genomic"DNA."Primers"were"purchased"from"IDT"
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(Laboratorios" Conda" S.A.," Torrejon" de" Ardoz," Spain)." Real=time" quantitative" RT=PCR" analysis" was"
carried" out" using" SYBR" green" I" dye" detection" (#11761500," Invitrogen)" using" the" iCycler" iQTM"
Multicolor" Real=Time" Detection" System" (Bio=Rad," Hercules," CA," USA)." Optimized" thermal" cycling"
conditions"were:"1"min"at"50°C,"8"min"and"30"sec"at"95°C"and"40"cycles"of"15"sec"at"95°C"and"30"sec"at"
60°C." Data" were" collected" after" each" cycle" and" graphically" displayed" (iCycler" iQTM" Real=time"
Detection"System"Software,"version"3.1,"Bio=Rad)."Melt"curves"were"performed"upon"completion"of"
the" cycles" to" ensure" specificity" of" the" product" amplification."Housekeeping" gene" for" normalization"
was" succinate" dehydrogenase" complex" subunit" A" (SDHA)." Data" were" analysed" with" the" 2=ΔΔCT"
method."For"comparison"purposes,"values"of"the"samples"of"each"group"(n=8=10"mice"per"group)"are"
expressed"as"fold"versus"the"mean"(n=7"mice)"value"of"the"control"non=injected"group."
*
Statistical*analyses*
Statistical"analyses"of"the"T2"relaxation"times"and"MTR"were"performed"separately"on"the"mean"value"
of"the"splenium"using"(i)"a"one=way"ANOVA"for"group"comparison"prior"to"cuprizone"administration"
(W0)"and"(ii)"using"a"(random"effects)"linear"regression"model"for"group"comparison"after"four"weeks"
of"cuprizone"administration,"as"described"by"the"following"equations:""Y! = Δ!! = T2!" − T2!",!Y! = Δ!"# = MTR!" −MTR!"."
with"Y1"and"Y2"defined"as"the"difference"between"the"mean"T2"relaxation"times"or"the"mean"MTR"after"
four" weeks" of" cuprizone" administration" (W4)" and" W0." For" the" EC," statistical" analyses" of" the" T2"
relaxation" times" and"MTR"were" performed" separately" on" the"mean" value" of" the" left" and" right" EC"
using" a" linear" mixed" model." The" obtained" p=values" were" corrected" for" multiple" testing" using" the"
Tukey"HSD"post=hoc"test.""
For"the"results"obtained"from"histological"analyses"the"following"statistical"analyses"were"applied:"(i)"
Comparison"between"experimental"groups"in"cellular"density"for"CC=1+"cells"and"F4/80+"cells"as"well"
as"the"coverage"percentage"of"MBP"and"GFAP"were"analyzed"using"one=way"ANOVA,"and"the"given"p=
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values"were"corrected"for"multiple"testing"using"the"Tukey"HSD"post=hoc"test."(ii)"The"appearance"of"
MHCII=" and" Arg1=expressing" F4/80" cells" was" analyzed" using" one" sample" t" test." (iii)" Comparison"
between"groups"in"cellular"density"of"eGFP+"macrophages"were"analyzed"using"generalized"estimating"
equations"(GEE),"with"the"given"p=values"being"corrected"for"multiple"testing"using"the"false"discovery"
rate" method." (iv)" The" appearance" of" MHCII=" and" Arg1=expressing" eGFP=" microglia" and" eGFP+"
macrophages"was"analyzed"using"GEE,"with" the"given"p=values"being" corrected" for"multiple" testing"
using"the"false"discovery"rate"method."(iv)"The"dependence"of"MBP"and"GFAP"coverage"percentage,"
and"cellular"density"for"CC=1+"and"F4/80+"between"T2"relaxation"times"or"MTR"was"measured"using"the"
Spearman's" correlation" coefficient." Correlation" coefficients" and" p=values" are" stated" in" the" results"
section."For"the"results"obtained"with"qRT=PCR,"group"comparison"was"performed"using"a"Wilcoxon"
rank"sum"test"with"FDR"correction."All"of"the"above"data"and/or"analyses"are"presented"either"in"dot"
plots"or"in"graphs"showing"mean"±"standard"deviation"(SD)"or"standard"error"of"the"mean"(SEM),"as"
indicated"in"the"figure"legends."A"p=value"of"<0.05"was"considered"statistically"significant."All"p=values"
–"whether"or"not"significant"="are"indicated"in"the"Supplementary"Tables"S2=S17."
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RESULTS*
*
Non$invasive*magnetic*resonance*imaging*reveals*less*severe*T2*and*MTR*deviation*in*the*splenium*
of*cuprizone*treated*mice*following*IL$13*LV*injection.***
Before" initiating" therapeutic" experiments," correct" stereotactic" targeting"of" the" LV" injections" to" the"
splenium"was"optimised"using"the"BFP"LV"and"validated"by"means"of"histological"analysis"(Figure"1a)."
In" order" to" investigate" the" effect" of" IL=13" expression" in" the" splenium" on" cuprizone" induced"
inflammation"and"demyelination,"non=injected"control"mice"(No"inj.),"blue"fluorescent"protein"(BFP)"
LV"injected"mice"and"IL=13"LV"injected"mice"were"randomly"assigned"to"a"subgroup"that"received"a"4=
week"regular"rodent"diet"(CONTROL)"or"a"subgroup"that"received"a"4=week"cuprizone"supplemented"
diet" (CUPRIZONE)" (Figure"2a)." This"4=week" time"point"was" chosen"as" it" corresponds" to" the"optimal"
time"window" in" the"cuprizone"mouse"model" comprising" the"highest" level"of"microglia/macrophage"
activation"with"extensive"demyelination"in"the"splenium(Praet"et"al."2014a)."In"this"part"of"the"study,"
non=invasive"MRI"was"performed"on"all"mice"prior" to" LV" injection"and/or" cuprizone"administration"
and" at" the" end" of" the" 4=week" study" period." For" analysis" of" MRI" data," regions" of" interest" were"
delineated" on" obtained" T2" and"MTR"maps" at" the" level" of" the" splenium" (Figure" 1b" upper" row)." No"
significant" differences" in" T2" or"MTR" values" were" observed" between" the" 6" different" groups" at" the"
beginning"of"the"experiment"(Supplementary"Figure"S1)."After"4"weeks,"while"non=injected"mice,"BFP"
LV"injected"mice"and"IL=13"LV"injected"mice"that"received"a"regular"rodent"diet"displayed"T2"and"MTR"
values"comparable"to"baseline"values"(respectively"Figures"2b"+"2d"and"2c"+"2e,"CONTROL"No"inj.,"BFP"
and"IL=13),"mice"that"received"the"cuprizone"supplemented"diet"without"LV"injection"or"with"injection"
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of" the"BFP" LV"displayed" significantly" increased"T2" values"and" significantly"decreased"MTR"values"at"
the"level"of"the"splenium"(respectively"Figures"2b"+"2d"and"2c"+"2e,"CONTROL"versus"CUPRIZONE"No"
inj."and"BFP)."These"observations"are"suggestive"for"inflammation"and"demyelination"in"the"splenium."
Interestingly,"cuprizone"treated"mice"expressing"IL=13"in"the"splenium"displayed"a"significantly"lower"
deviation"of"the"normal"T2"and"MTR"values"at"the"level"of"the"splenium"as"compared"to"non=injected"
or" BFP" LV" injected" cuprizone" treated"mice" (Figures" 2b" +" 2d" and" 2c" +" 2e," CUPRIZONE" IL=13" versus"
CUPRIZONE"No" inj." and"CUPRIZONE"BFP)." Lastly,"we"noted"a" strong" inverse"correlation"between"T2"
and" MTR" values" (Figure" 2f)," implying" that" T2" and" MTR" changes" may" be" indicative" of" similar" or"
associated"pathological"alterations." In" summary," the"presented"data" show" that" IL=13" immune"gene"
therapy"in"the"splenium"strongly"decreases"cuprizone"induced"pathological"alterations"as"assessed"by"
non=invasive"MRI"measurements."
"
IL$13*LV*injection*in*the*splenium*prevents*cuprizone$induced*inflammation,*oligodendrocyte*death*
and*demyelination.##
In" order" to" further" validate" our" imaging" observations," quantitative" histological" analyses" were"
performed."As"expected,"mice"that"received"the"cuprizone"supplemented"diet"without"LV"injection"or"
with"injection"of"the"BFP"LV"displayed"a"significantly"lower"number"of"CC=1+"oligodendrocytes"in"the"
splenium,"which"further"resulted"in"severe"demyelination,"as"demonstrated"by"the"significant"loss"of"
myelin" basic" protein" (MBP)" expression" in" the" splenium" (Figures" 3a" and" 3b," CONTROL" versus"
CUPRIZONE" No" inj." and" CUPRIZONE" BFP)." Additionally," significant" recruitment" of" F4/80+" activated"
microglia/macrophages" was" observed" in" mice" that" received" the" cuprizone" supplemented" diet"
without"LV"injection"or"with"injection"of"the"BFP"LV"(Figures"3c,"CONTROL"versus"CUPRIZONE"No"inj."
and" CUPRIZONE" BFP)." The" presence" of" activated" microglia/macrophages" was" further" confirmed"
following"staining"with"an"anti=Iba1"antibody"and"an"anti=CD11b"antibody"(Supplementary"Figure"S2)."
Similarly,"significant"astrocyte"activation,"as"demonstrated"GFAP+"astrogliosis,"was"observed"in"mice"
that"received"the"cuprizone"supplemented"diet"without"LV" injection"or"with" injection"of"the"BFP"LV"
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(Figures" 3d," CONTROL" versus" CUPRIZONE" No" inj." and" CUPRIZONE" BFP)." In" contrast," as" already"
suggested"by" the"MRI" analyses," cuprizone" treated"mice" expressing" IL=13" in" the" splenium"displayed"
significantly" higher" CC=1+" oligodendrocyte" numbers" and" less" demyelination" as" compared" to" non=
injected" or" BFP" LV" injected" cuprizone" treated" mice" (Figures" 3a" and" 3b," CUPRIZONE" IL=13" versus"
CUPRIZONE"No"inj."and"CUPRIZONE"BFP)."Interestingly,"cuprizone"treated"mice"expressing"IL=13"in"the"
splenium"also"displayed"significantly"reduced"recruitment"of"F4/80+"activated"microglia/macrophages"
(Figure" 3c," CUPRIZONE" IL=13" versus" CUPRIZONE" No" inj." and" CUPRIZONE" BFP)," further" confirmed"
following"staining"for"Iba=1"and"CD11b"(Supplementary"Figure"S2)."In"addition,"also"GFAP+"astrogliosis"
was"significantly"decreased"as"compared"to"non=injected"or"BFP"LV" injected"cuprizone"treated"mice"
(Figure"3d,"CUPRIZONE"IL=13"versus"CUPRIZONE"No"inj."and"CUPRIZONE"BFP)."In"agreement"with"our"
conclusion" from" the" MRI" analyses," histological" data" thus" confirms" that" IL=13" LV" injection" in" the"
splenium" decreases" cuprizone" induced" inflammatory" responses" and" subsequent" oligodendrocyte"
death"and"demyelination."Furthermore,"given"the"large"dataset"obtained,"we"performed"a"correlation"
analysis" between" MRI" metrics" and" histological" metrics" at" the" level" of" the" splenium" for" all"
experimental"groups."At"one"hand,"Spearman"correlation"coefficients"revealed"an"inverse"correlation"
between"T2"values"and"the"oligodendrocyte/myelin"markers"CC=1"and"MBP"(Supplementary"Figure"S3,"
ρ" =" =0.8154" and" ρ" =" =0.7997," respectively)" and" a" positive" correlation" between" T2" values" and" the"
inflammation=associated" markers" F4/80" and" GFAP" (Supplementary" Figure" S3," ρ" =" 0.8506" and" ρ" ="
0.7716," respectively)." On" the" other" hand," MTR" values" display" a" positive" correlation" with" the"
oligodendrocyte/myelin"markers"CC=1"and"MBP"(Supplementary"Figure"S3,"ρ"="0.7990"and"ρ"="0.8318,"
respectively)"and"an" inverse"correlation"with"the" inflammation=associated"markers"F4/80"and"GFAP"
(Supplementary"Figure"S3,"ρ"="=0.8929"and"ρ"="=0.8229,"respectively)."Concluding,"and"in"agreement"
with"preceding"studies"(Acs"et"al."2009;"Boretius"et"al."2012;"Chandran"et"al."2012;"Harsan"et"al."2008;"
Thiessen"et"al."2013;"Torkildsen"et"al."2009),"both"T2"and"MTR"values"can"be"used"as"predictive"norms"
for" monitoring" cuprizone" induces" inflammatory" and" demyelinating" events," including" therapeutic"
intervention"thereon."
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IL$13* LV* injection* in* the* splenium* protects* locally* during* cuprizone$induced* inflammation,*
oligodendrocyte*death*and*demyelination.#
Given" the"potential"of" IL=13" to" interfere"with" the"development"of" inflammatory"and"demyelinating"
events" following"cuprizone"treatment,"we"additionally" investigated"whether"the"beneficial"effect"of"
IL=13"is"restricted"to"the"LV"injection"site"(i.e."the"splenium),"or"whether"protection"can"be"observed"
at" cuprizone"affected" sites"distinct" from" the" splenium."For" this," additional" regions"of" interest"were"
delineated"on"obtained"T2"and"MTR"maps"in"the"external"capsule"at"the"level"of"the"genu"(Figure"1b,"
lower"row)."Here,"all"cuprizone"treated"mice"display"significantly"increased"T2"values"and"significantly"
decreased" MTR" values" as" compared" to" control" groups" indicating" extensive" demyelination" and"
inflammation"in"the"external"capsule"(Figures"4a"and"4b,"CONTROL"versus"CUPRIZONE)."Interestingly,"
MTR,"but"not"T2"was"able"to"detect"a"lower"deviation"of"the"normal"MTR"for"mice"that"received"the"
cuprizone"diet"and" the" IL=13"LV" injection"as"compared" to"mice" that" received"cuprizone"and"BFP"LV"
injection"or"no"injection"(Figure"4b"CUPRIZONE"IL=13"versus"CUPRIZONE"No"inj."and"CUPRIZONE"BFP)."
Further" histological" analyses," as" shown" by" the" representative" images" provided" in" figure" 4," clearly"
showed" a" loss" of" CC=1+" oligodendrocytes" (Figure" 4c)," demyelination" (Figure" 4d),"
microglia/macrophage"recruitment"(Figure"4e)"and"astrogliosis"(Figure"4f)"at"the"level"of"the"external"
capsule"in"cuprizone"treated"mice"as"compared"to"the"control"mice."Correlation"analyses"confirmed"
the"findings"reported"for"the"splenium"of"the"CC,"i.e."an"inverse"correlation"between"T2"and"MTR"(ρ"="
=0.7666,"p"<"0.0001)"and"similar"association"of"MRI"metrics"with"histological"markers"(Supplementary"
Figure"S4)"at"the"level"of"the"external"capsule."Altogether"these"data"suggest"that"expression"of"IL=13"
in" the" splenium" alters" the" response" to" cuprizone" diet," but" is" not" sufficient" to" rescue" cuprizone=
induced"pathology"in"regions"distinct"from"the"LV"injection"site."
"
IL$13* LV* injection* in* the* splenium* alters* phenotypical* properties* of* activated* F4/80+*
microglia/macrophages*during*cuprizone*treatment.*
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In"order"to"further"understand"the"observed"protective"effect"of" IL=13"LV" injection" in"the"splenium,"
we" investigated" the"expression"of"major"histocompatibility" complex"class" II" (MHCII)"and"Arginase=1"
(Arg=1)"by"activated"F4/80+"microglia/macrophages."As"already"described"above"(Figure"3c),"mice"that"
received" the" cuprizone" supplemented" diet" without" LV" injection" displayed" a" significant" increase" of"
F4/80+"microglia/macrophages"at"the"level"of"the"splenium"compared"to"control"mice"(Figures"5a"and"
5b," CUPRIZONE" No" inj." versus" CONTROL" No" inj.," BFP" LV" and" IL=13)." Interestingly," a" significant"
subpopulation"of"F4/80+"activated"microglia/macrophages" in"cuprizone"treated"mice"displays"MHCII"
expression"upon"BFP"LV"or" IL=13"LV" injection"(Figure"5a,"CUPRIZONE"No" inj."versus"CUPRIZONE"BFP"
and" IL=13)." Note" that" this" subpopulation" of" MHCII+" F4/80+" activated" microglia/macrophages" also"
significantly" appears" following" BFP" LV" injection" in" control" mice" (Figure" 5a," CONTROL" BFP)."
Furthermore,"a" significant" subpopulation"of"F4/80+"activated"microglia/macrophages"displays"Arg=1"
expression"upon"IL=13"LV"injection"only"in"cuprizone"treated"mice"(Figure"5b"CUPRIZONE"IL=13"versus"
CUPRIZONE" No" inj." and" BFP)." Next," we" investigated" whether" the" observed" F4/80+MHCII+" and"
F4/80+Arg=1+"cells"are" independent"cell"populations"or"whether"they"are"the"same"cell"population."
Interestingly,"upon"co=staining"of"MHCII"and"Arg=1,"it"is"clear"that"cuprizone"treated"mice"expressing"
IL=13" present" three" distinct" populations" of" cells" which" either" are"MHCII+," Arg=1+" or" Arg=1+=MHCII+,"
with"the" latter"two"being"the"most"prominent" (Figure"5c,"CUPRIZONE"IL=13)."Summarizing,"we"here"
demonstrate"that"LV"injection,"either"BFP"LV"or"IL=13"LV,"can"modulate"the"activation"state"of"F4/80+"
activated" microglia/macrophages" as" demonstrated" by" the" expression" of" MHCII." Additionally,"
expression" of" IL=13" was" able" to" induce" Arg=1" expression" in" activated" F4/80+" and" F4/80+MHCII+"
microglia/macrophages," which"might" account" for" the" beneficial" effects" observed" on" inflammation"
and"demyelination."""
"
IL$13*LV*injection*in*the*splenium*induces*a*unique*phenotype*and*cytokine*profile*during*cuprizone*
treatment.*
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In"order"to"further"extend"our"hypothesis"that"IL=13"is"capable"of"modulating"inflammatory"responses"
in" cuprizone" treated" mice," we" determined" the" mRNA" expression" levels" of" multiple" cytokines" and"
immune"phenotype"markers"at"the"level"of"the"CC"in"different"experimental"groups"by"means"of"qRT=
PCR." At" first," it" is" clear" that" mRNAs" encoding" Arg=1," YM=1" and" Gal=3," which" are" associated" with"
alternative"microglia/macrophage"activation,"are"significantly"up=regulated"in"cuprizone"treated"mice"
injected" with" IL=13" LV," as" compared" to" healthy" control" and" non=injected" cuprizone" treated" mice"
(Figures" 6a," 6b" and" 6c)." While" the" pro=inflammatory" cytokines" TNF=α," IL=1β" and" iNOS" were"
significantly"up=regulated" in"cuprizone" treated"mice" injected"with" the"BFP"LV"mice,"but"not" in"non=
injected" cuprizone" treated" mice," cuprizone" treated" mice" injected" with" IL=13" LV" were" able" to"
counteract"TNF=α,"but"not"IL=1β"expression"(Figures"6d,"6e"and"6f)."Unexpectedly,"a"small"increase"of"
iNOS"mRNA"was"detected" in" cuprizone" treated"mice" injected"with" IL=13" LV" (Figure"6f)."Concluding,"
our" results" demonstrate" that" in" vivo" LV" mediated" IL=13" expression" is" capable" to" induce" mRNA"
expression"associated"with"alternative"microglia/macrophage"activation,"which"might"lie"at"the"basis"
of" above=described" inflammatory/neuro=protective"effects" in" the" cuprizone"mouse"model," but" also"
indicates"that"LV"mediated"gene"transfer"on"its"own"can"shift"neuro=inflammatory"responses"toward"
a"more"pro=inflammatory"character."Nevertheless,"downstream"IL=13"events"are"capable"="at"least"in"
part"="to"counteract"LV"mediated"reinforcement"of"inflammatory"responses."
"
Both*microglia*and*macrophage*phenotype*is*modulated*through*LV*mediated*expression*of*IL$13*
in*the*splenium.***
As" the" initiation" and" modulation" of" neuro=inflammation" is" a" complex" interplay" between" brain"
resident"microglia"and"peripheral" immune"cells,"we"here" investigated"whether"any"of" the"observed"
MHCII+," Arg=1+" or" MHCII+Arg=1+" cell" populations" can" be" specifically" linked" to" microglia" and/or"
macrophage"cell"populations."For"this,"we"generated"8=week"old"eGFP+"bone"marrow"chimeras"that"
were"subjected"to"BFP"LV"or"IL=13"LV"injection"followed"by"4"weeks"of"cuprizone"administration."Non=
injected"cuprizone"treated"eGFP+"bone"marrow"chimeras"served"as"control"in"this"experimental"setup"
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(Figure"7a)."Cuprizone=induced"pathology"and" IL=13"LV"protection"was" first"verified"by"means"of"T2=
weighted" imaging" (Figure" 7b)." In" agreement" with" the" above=described" results," MHCII+" cells" were"
detected"in"both"BFP"LV"and"IL=13"LV"injected"mice,"while"Arg=1+"cells"were"only"detected"in"IL=13"LV"
injected"mice" (Figure" 7c," second" +" third" column)." Based" on" eGFP" expression," which" discriminates"
infiltrating"eGFP+"peripheral"macrophages"from"brain"resident"eGFP="microglia,"it"can"be"noted"that"a"
significantly"higher"number"of"eGFP+"peripheral"macrophages"contributes"to"="or"at"least"are"present"="
within" cuprizone" induced" inflammatory" lesions" in" the" splenium" upon" BFP" LV" or" IL=13" LV" injection"
(Figure" 7c," first" column;" Figure" 7d," No" inj." versus" BFP" and" IL=13)." Further" co=localisation" studies"
revealed"that"MHCII"is"expressed"by"both"eGFP+"macrophages"and"eGFP="microglia"upon"control"BFP"
LV" (Figure" 7c," fourth" column"middle" image;" Figure" 7e," BFP)." Similarly" =" and"highly" interesting" =" co=
localisation" studies" reveal" that" expression" of" IL=13" in" the" splenium" by" means" of" LV" injection" and"
subsequent"cuprizone"administration" leads"to"the"significant"appearance"of"4"distinct" inflammatory"
cell" populations:" MHCII+," Arg=1+" and" Arg=1+MHCII+" eGFP+" macrophages" and" Arg=1+MHCII+" eGFP="
microglia" (Figure" 7c," fourth" column" lower" image;" Figure" 7e," IL=13)." These" data" indicate" that" both"
infiltrating"macrophages"and"brain=resident"microglia"have"the"capacity"to"display"Arg=1"expression"in"
vivo" upon" stimulation" with" IL=13," and" thereby" potentially" contribute" to" the" beneficial" effects"
observed"on"inflammation"and"demyelination."""
"
Therapeutic* LV*mediated* expression* of* IL$13* in* the* splenium* protects* against* severe* cuprizone$
induced*demyelination*and*is*associated*with*an*altered*microglia/macrophages*phenotype.*
Finally,"we"further"investigated"whether"IL=13"LV"injection"may"also"exert"neuro=protective"effects"in"
a"therapeutically"relevant"setup."For"this,"mice"received"a"cuprizone"supplemented"diet"for"a"period"
of" 2.5" weeks" in" order" to" trigger" a" neuro=inflammatory" response" and" oligodendrocyte" metabolic"
impairment."After"2.5"weeks"of"cuprizone"treatment,"mice"received"an"injection"of"the"IL=13"LV"and"
were" kept" under" cuprizone" diet" for" an" additional" 1.5" weeks," after" which" MRI" evaluation" and"
histological"analyses"were"performed"(Figure"8a)."While"preservation"of"the"splenium"of"the"CC"can"
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be"observed"on"T2"maps"and"on"color=coded"MTR"images"of"IL=13"LV"injected"cuprizone"treated"mice,"
only"MTR"revealed"a"significantly" lower"deviation"of"the"normal"MTR" in" IL=13"LV" injected"cuprizone"
treated" mice" as" compared" to" non=injected" cuprizone" treated" mice" (Figures" 8b," 8c" and" 8d)."
Histological"analyses"confirmed"the"presence"of"oligodendrocytes"and"myelin"(Figure"8e,"left"panels)"
in" cuprizone" treated" mice" that" received" the" IL=13" LV" injection." Importantly," and" in" line" with" the"
findings" reported" above," this" neuro=protection" was" associated" with" the" presence" Arginase1" and"
MHCII" expressing" microglia" and" macrophages" (Figure" 8e," right" panels)." In" summary," our" results"
suggest" that" LV"mediated" expression" of" IL=13" in" a" pre=existing" neuro=inflammatory" environment" is"
capable" of" counteracting," at" least" in" part," severe" cuprizone=induced" demyelination" and" is" strongly"
associated"with"the"appearance"of"alternatively"activated"microglia/macrophages.""
* *
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DISCUSSION"
"
Halting" the" progression" of" brain" damage" while" preventing" and" limiting" further" pathological"
alterations"are"critical"steps"for"the"treatment"of"progressive"neurodegenerative"diseases"such"as"MS"
(Giunti" et" al." 2014;" Goldmann" and" Prinz" 2013;" van" Noort" et" al." 2011)." In" this" study," we" used" the"
cuprizone" mouse" model" of" MS" to" induce" highly" inflammatory" demyelinating" lesions" in" the" white"
matter"(Gudi"et"al."2014;"Gudi"et"al."2009;"Orije"et"al."2015;"Remington"et"al."2007;"Steelman"et"al."
2012)" and" subsequently" demonstrate" that" targeted" delivery" of" IL=13" to" the" lesion" site," prior" and"
during" lesion" induction," induced" the" expression" of"markers" characteristic" for" alternative" activation"
both"in"microglia"and"macrophages."The"latter"is"here"shown"to"be"associated"with"a"protective"effect"
on" oligodendrocyte" survival" and" subsequently" less" severe" demyelination" during" cuprizone"
administration." These" results" are" fully" in" line" with" current" understandings" of" neuro=inflammatory"
processes"in"health"and"disease"(Cherry"et"al."2014;"Murray"et"al."2014;"Rawji"and"Yong"2013),"which"
suggest" that" modulating," rather" than" suppressing," microglial" activation" may" be" a" more" adequate"
therapeutic"approach"(David"and"Kroner"2011;"Tang"and"Le"2015)."Because"microglia"share"functional"
similarities" with" peripheral" macrophages," microglial" activation" and" polarization" state" is" generally"
classified"using"the"established"macrophage’s"nomenclature,"i.e."classically"activated,"also"referred"as"
M1=like" phenotype," or" alternatively" activated," also" referred" as" M2=like" phenotype," which" in" turn"
comprises"several"subtypes"of"cell"activation"(David"and"Kroner"2011;"Hu"et"al."2012)."In"the"present"
study,"we" report" on" the" in# vivo" induction" of" arginase1" expressing" alternatively" activated"microglia"
and"macrophages"following"LV"mediated"delivery"of"IL=13,"similar"to"IL=4"a"well"described"inducer"of"
this" specific" subset" of" alternatively" activated" microglia" and" macrophages" (Franco" and" Fernandez=
Suarez" 2015;"Orihuela" et" al." 2015)."Of" note," although" not" described" in" detail" in" this"manuscript," a"
similar" set" of" experiments" using" an" IL=4" encoding" LV" also" demonstrates" similar" protection" against"
demyelination"upon"injection"into"the"splenium"of"cuprizone"treated"mice"(Supplementary"Figure"S5"
and" Supplementary" Table" S17)." Following" IL=13" LV" administration," as" well" as" following" IL=4" LV"
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administration,"the"alternatively"activated"state"was"associated"with"the"prevention"of"the"cuprizone=
induced" pathology." The" latter" may" not" be" unexpected" as" IL=4" and" IL=13" share" common" receptor"
components" (Kelly=Welch" et" al." 2003;" Van" Dyken" and" Locksley" 2013)," but" may" display" divergent"
effects" on"microglia" and"macrophages."While"macrophages" generally" are"directed" towards" the"M2"
activation" state" (Dhakal" et" al." 2014;" Murray" et" al." 2014;" Orihuela" et" al." 2015)," microglia" may"
additionally" be" forced" into" apoptotic" death" under" certain" conditions" following" IL=4/13" stimulation"
(Won"et"al."2013;"Yang"et"al."2002)."At"the"time"mentioned,"we"did"not"observe"obvious"differences"
between"IL=13"and"IL=4"mediated"neuroprotection,"and"therefore"decided"to"narrow"down"this"study"
to"the"administration"of"IL=13,"without"specific"preference.""
"
In,situ"delivery"of"compounds"can"be"achieved"through"several"means,"including"direct"intracerebral"
injection"of"the"molecule"of"interest"(Kawahara"et"al."2012)," inoculation"of"nano=sized"vehicles"such"
as" liposomes" or" nanoparticles" containing" the" selected" compound" (Malam" et" al." 2009)," direct"
engraftment"of"engineered"cells"producing"the"protein"of"interest"(Stuckey"and"Shah"2014;"Tan"et"al."
2005)," or" gene" transfer" using" altered" machinery" of" viruses" (Houghton" et" al." 2015)." Following" our"
approach" using" LV" injections" in" brains" of" healthy" and" cuprizone" treated" mice," several" interesting"
observations" were"made." As" observed" on" Figure" 3," LV" injections" resulted" in" a" slight" activation" of"
microglia"and"macrophages"(Figure"3c,"F4/80)"and"upregulation"of"MHCII"expression"in"case"of"BFP"LV"
injections"in"control"mice"(Figures"5a"and"5c,"MHCII),"most"likely"illustrating"the"response"to"the"viral"
particles" and" the" attempt" to"eliminate" them."Remarkably," in" case"of" cuprizone" administration," the"
vast" majority" of" microglia" and" infiltrating" macrophages" at" the" level" of" the" LV" injection" showed"
upregulation"of"MHCII,"both"in"case"of"BFP"or"IL=13"LV"injections"(Figures"5,"7c,"7e"and"8e),"while"only"
very"little"MHCII"expression"was"observed"in"case"of"cuprizone"treated"mice"that"did"not"received"a"
LV" injection." These" alterations" in" the" pro=inflammatory" phenotype" following" cuprizone"
administration" in"BFP" LV" injected"animals"was" further" confirmed"by" the" significant"upregulation"of"
TNF=α"mRNA"(Figure"6d)"and,"albeit"at"a"lower"degree,"the"significant"upregulation"of"IL=1β"and"iNOS"
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mRNA" (Figures" 6e" and" 6f)." These" results" are" in" line" with" previous" studies" showing" that" LV"
transduction" can" elicit" a" transient" pro=inflammatory" response" against" the" LV" particles" (Kay" 2011),"
mediated" by" the" activation" of" toll=like" receptor" 7" and" or" toll=like" receptor" 9," which" respectively"
recognize" single" stranded" RNA" and" unmethylated" CpG" (Matrai" et" al." 2010)." Consequently," the"
exacerbated"immune"response"observed"following"cuprizone"administration"in"BFP"LV"injected"mice"
can" be" explained" by" a" possible" priming" effect" of" innate" immune" cells" following" lentiviral" vector"
infection"and/or"by"the"high"infiltration"of"peripheral"macrophages,"caused"by"a"blood"brain"barrier"
breakdown" at" the"moment" of" the" intracerebral" surgery" (Figure" 7d)," thereby"modifying" the" lesion"
environment"as" compared" to"mice" that"did"not" received"a" LV" injection" (no"mechanical"blood=brain"
barrier" damage" and" limited" recruitment" of" peripheral"macrophages)." Likewise,"we" cannot" exclude"
that"priming"of"innate"immune"cells"following"lentiviral"vector"infection"may"be"the"key"to"successful"
IL=13" mediated" deviation" from" classically" activated" towards" alternatively" activated" microglia" and"
macrophages," the" latter"upregulating," next" to"MHCII" (Zurawski" and"de"Vries" 1994)," also" arginase1,"
YM=1"and"galectin=3"(Figure"5b"and"5c,"Figure"6"a=c,"Figure"7c"and"7e,"Figure"8e),"which"we"associate"
with" the" beneficial" effect" on" oligodendrocyte" survival" and"myelin" preservation." Interestingly," IL=13"
was"also"able"to"counteract"the"upregulation"of"TNF=α"mRNA"as"a"consequence"of"LV"injection."This"is"
highly"interesting"in"view"of"the"observation"that"in"TNF=α"knock=out"mice"cuprizone"administration"
results" in"a"higher"survival"of"oligodendrocytes"and"preservation"of"myelin"up" to"4"weeks"after" the"
start" of" the" cuprizone"diet" (Arnett" et" al." 2001)." Furthermore," our" observations" that" IL=13" (and" IL=4"
immune" gene" therapy," Supplementary" Figure" S5" and" Supplementary" Table" S17)" is" able" to" exert"
beneficial" effects" on" neuro=inflammation" and" demyelination" in" the" cuprizone"mouse"model" is" also"
further" supported"by" a" recent" publication"by" Janssens" et" al." showing" that" LV"mediated"delivery" of"
oncostatin" M" (OSM)" can" induce" alternatively" activated" microglia" and" macrophages" via" the"
upregulation" of" IL=4" expression," resulting" in" protection" against" cuprizone=induced" demyelination"
(Janssens"et"al."2015).""
"
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Although"the"main"aim"of"this"study"was"to"investigate"the"influence"of"IL=13"immune"gene"therapy"
on" inflammation" and" demyelination," an" important" aspect" that" still" remains" to" be" elucidated" is"
whether"alternatively"activated"microglia"and"macrophages"stimulated"by"the"addition"of"IL=13"would"
play"a"beneficial"role"in"the"repair"process"and"remyelination"once"cuprizone"administration"is"halted."
While" in" our" hands" no" classical" M1=" or" M2=associated" phenotypic" markers" can" be" found" in" the"
cuprizone" model," a" few" studies" have" shown" that" microglia" and" macrophages" display" a" distinct"
phenotype"supportive"of"remyelination"(Gudi"et"al."2011;"Morell"et"al."1998;"Olah"et"al."2012;"Voss"et"
al." 2012)." Along" with" the" secretion" of" anti=inflammatory" factors," growth" factors" and" neurotrophic"
factors,"there" is"accumulating"evidence"that"phagocytosis"of"myelin"debris" is"an"essential"step"for"a"
successful"remyelination"and"that"this"step" is"ensured"by"alternatively"activated"polarized"microglia"
and" macrophages" (Cantoni" et" al." 2015;" Lampron" et" al." 2015;" Poliani" et" al." 2015;" Skripuletz" et" al."
2013)." Furthermore," in" the" past" years," numerous" studies" have" reported" the" beneficial" effect"
operated"by"the"shift"from"M1="to"M2=polarized"immune"cells"in"other"preclinical"models"of"MS"and"
other"models"of"neuro=inflammation"(Cash"et"al."1994;"Janssens"et"al."2015;"Liu"et"al."2013;"Miro=Mur"
et"al."2015;"Miron"et"al."2013;"Morganti"et"al."2015;"Ponomarev"et"al."2007;"Yu"et"al."2015;"Zhao"et"al."
2015)."Specifically"narrowing"down"on"the"distinct"roles"of"microglia"and"macrophages"in"natural"or"
therapeutic"neuroprotection"and/or"repair,"it"will"be"of"utmost"importance"to"carefully"design"future"
studies" allowing" discrimination" between" both" cell" populations." Especially" for" the" cuprizone"mouse"
model," prior" studies" using" bone" marrow" chimeric" mice" have" reported" that" the" population" of"
monocyte=derived"macrophages"recruited"to"the"corpus"callosum"following"cuprizone"administration"
represents"5"to"30%"of"the"total"number"of"microglia/macrophages(Lampron"et"al."2015;"Remington"
et"al."2007;"Voss"et"al."2012)" in" the"absence"of"BBB"disruption(Arnett"et"al."2001;"Matsushima"and"
Morell"2001)."Similarly,"we"used"bone"marrow"chimeric"mice"to"discern"whether"resident"microglia"
and"infiltrating"monocyte=derived"macrophages"were"equivalently"affected"by"IL=13"stimulation"and"
found" that" both" populations" displayed" an" alternatively" activated" phenotype" (Figure" 7c" and" 7e)."
Recently" it" has" however" been" clearly" shown" that" radiation" bone"marrow" chimeric"mice" display" an"
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altered" BBB" permeability" to" systemic" monocytes(Morganti" et" al." 2014)," suggesting" that" certain"
results" need" caution" during" interpretation" as" the" function" and" recruitment" of" peripheral"
macrophages"may"slightly"differ"from"non=irradiated"non=injected"animals."Nevertheless,"our"results"
were" already" able" to" demonstrate" that" IL=13" act" on" both" microglia" and" infiltrating" macrophages,"
while" future" experiments" to" be" performed" in" the" CX3CR1eGFP/+CCR2RFP/+" transgenic" mouse" model"
would"surely"help"in"further"addressing"these"issues(Saederup"et"al."2010)."
"
Finally,"we"would"like"to"elaborate"a"little"further"on"our"choice"to"non=invasively"detect"white"matter"
lesions"using"multiparametric"MRI."To"date,"MRI"represents"the"method"of"choice"for"the"evaluation"
and" monitoring" of" demyelinating" lesions" over" time" in" patients" suffering" from" MS" (Polman" et" al."
2011)." We" used" T2" relaxometry," a" method" routinely" used" in" clinical" settings" (Poloni" et" al." 2011;"
Wattjes"et"al."2015),"in"combination"with"a"newly"described"method,"magnetization"transfer"imaging"
that"is"sensitive"to"the"integrity"of"macromolecules,"notably"myelin"in"the"CNS"(Grossman"1994;"Ou"et"
al."2009;"Turati"et"al."2015)."We"demonstrated"that"both"T2"and"MTR"measures"are"highly"correlated"
to" the" brain" microstructure" and" underlying" histopathological" events" following" cuprizone"
administration" (Supplementary" Figure" S3" and" S4)." Although" a" few" studies" have" associated" MTR"
values"to"oligodendrocytes"numbers,"myelin"and"GFAP"positive"astrocytes"(Boretius"et"al."2012;"Fjaer"
et"al."2013;"Merkler"et"al."2005;"Thiessen"et"al."2013;"Zaaraoui"et"al."2008),"we"were"unable"to"ascribe"
a"specific"MRI"metric"to"a"specific"histological"event."This"is"likely"due"to"the"fact"that"we"used"a"four"
week"cuprizone"regime"in"which"neuro=inflammation"and"demyelination"are"both"reaching"maximal"
values" while" other" studies" followed" cuprizone" induced" changes" over" time," hence" enabling" to"
differentiate"between"sequential"cellular"events."Additionally,"we"here"demonstrate"that"both"T2"and"
MTR" measures" are" suitable" to" detect" alterations" in" neuro=inflammation" and" associated"
demyelination" following" IL=13" LV" therapeutic" intervention." Moreover," we" also" show" that" MTI"
improved"the"detection"of" tissue"alterations"as"compared"to"T2,"as"MTI"values" reached"significance"
when"T2"displayed"a"trend"(Figures"4a"+"4b"and"8c"+"8d)," indicating"a"lower"sensitivity"threshold"for"
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MTI"and"highlighting"its"potential"for"future"use"in"clinical"practice."Moreover,"by"correlating"T2"and"
MTI"measurements"with" quantitative" histological" analyses," the"multimodal" character" or" this" study"
clearly"contributes"to"the"validity"of"the"observed"therapeutic"effect"of"IL=13"immune"gene"therapy.""
In" conclusion," the" results" presented" in" this" study" reveal" a" neuroprotective" role" of" IL=13" in"
demyelinating" lesions" through" the" induction" of" alternatively" activated"microglia" and"macrophages."
The" ability" of" IL=13" to" trigger" the" switch" from" a" pro=inflammatory" environment" towards" an" anti=
inflammatory" environment," and" thus" limit" CNS=induced" pathology," is" of" particular" interest" for" the"
design" of" new" drug" based" therapies" aiming" at" modulating" microglial" function" to" preserve" tissue"
homeostasis"and"support" remyelination" in"MS"and"other"demyelinating"diseases." In"addition," these"
findings" emphasize" the" beneficial" action" of" alternatively" activated" immune" cells" that" certainly"
deserve" to" be" investigated" in" other" pro=inflammatory=driven" CNS" pathological" conditions," such" as"
neurotrauma,"spinal"cord"injury"or"stroke."
*
* *
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FIGURE*LEGENDS"
*
Figure*1:*Stereotaxic*injection*and*MRI*delineations.*
(a)" Coordinates" for" stereotaxic" injections" of" LV" at" the" level" of" the" splenium" of" the" CC." A"
representative"direct" immunofluorescence"image"of"blue"fluorescent"protein"(BFP)"LV"injected"mice"
indicates"stable"expression"of"the"transgene"in"the"splenium"up"to"four"weeks"post"LV=injection."(b)*
Representative" images"of" a" control"mouse" indicating" in" red" the"delineations"of" the" two" regions"of"
interest,"i.e."the"splenium"and"the"external"capsule"on"a"T2"map"and"MTR"image."
*
Figure*2:*Non7invasive*magnetic*resonance*imaging*reveals*less*severe*T2*and*MTR*deviation*in*the*
splenium*of*cuprizone*treated*mice*following*LV*mediated*expression*of*IL713.***
(a)"To" induce" inflammation"and"demyelination,"mice"were"fed"a"cuprizone"supplemented"diet" for"a"
period"of"four"weeks,"while"mice"of"the"control"groups"were"fed"a"regular"rodent"chow."On"the"first"
day"of"cuprizone"administration"mice"received"an"injection"of"a"BFP"LV"or"IL=13"LV"or"no"injection"(No"
inj.)"and"were"assigned"to"a"cuprizone"or"control"group."MRI"was"performed"prior"to"LV"injection"and"
after"four"weeks"of"cuprizone"feeding,"immediately"followed"by"histological"analysis."(b)"Panel"shows"
a"representative"T2"map"for"each"experimental"group"at"the"level"of"the"splenium"of"the"CC."Hyper=
intense" contrast" can" be" visualized" at" the" level" of" the" splenium" after" cuprizone" administration,"
reflecting" inflammation" and/or" demyelination," but" not" for" mice" that" also" received" the" IL=13" LV"
injection"(white"arrows"indicate"the"location"of"the"CC"of"cuprizone"treated"mice)."Scale"bar"="1"mm."
(c)"In"a"similar"manner,"panel"shows"a"representative"color=coded"MTR"image"for"each"experimental"
group"at" the" level"of" the" splenium"of" the"CC."Disappearance"of" the"CC" (color=coded" in" red)" can"be"
observed" after" cuprizone" administration," indicating" inflammation" and" demyelination," but" not" for"
mice" that" also" received" the" IL=13" LV" injection" (white" arrows" indicate" the" location" of" the" CC" of"
cuprizone"treated"mice)."Scale"bar"="1"mm."(d)"T2"values"of"individual"mice"are"displayed"in"the"graph"
with"mean"±"SD"and"reveal"a"lower"deviation"of"the"normal"T2"of"IL=13"LV"injected"cuprizone"treated"
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mice"(n"=""5"="14"mice)."*P<0.05,"Linear"regression"model,"Tukey"post"hoc"test."All"p=values"–"whether"
or"not"significant"=""are"indicated"in"the"Supplementary"Table"S2."(e)"Similarly,"MTR"of"individuals"are"
displayed"in"the"graph"with"mean"±"SD"and"indicate"a"lower"deviation"of"the"MTR"of"IL=13"LV"injected"
cuprizone"treated"mice"(n"=""5"="14"mice)."(f)"Graph"showing"a"strong"inverse"correlation"between"T2"
values"and"MTR."*P<0.05,"***P<0.001,"Linear"regression"model,"Tukey"post"hoc"test."All"p=values"–"
whether"or"not"significant"=""are"indicated"in"the"Supplementary"Table"S3.""
"
Figure* 3:* LV* mediated* expression* of* IL713* in* the* splenium* prevents* cuprizone7induced*
inflammation,*oligodendrocyte*death*and*demyelination.""
Histological" analyses" performed" at" the" level" of" the" splenium" for" CC1+" oligodendrocytes," MBP"
myelination,"F4/80+"activated"microglia/macrophages"and"GFAP+"astrogliosis"are"depicted"in"panels"a,"
b," c" and" d," respectively," and" confirm" decreased" oligodendrocyte" cell" loss" and" demyelination"
associated"with"a"decreased"microgliosis"and"astrogliosis"in"IL=13"LV"injected"cuprizone"treated"mice."
*P<0.05," **P<0.01," ***P<0.001," One=way" ANOVA" and" Tukey" post" hoc" test" (n" =" 3" =" 6"mice)." All" p=
values" –"whether"or"not" significant" =" are" indicated" in" the" Supplementary" Tables" S4," S5," S6" and" S7."
Scale"bar"="100"μm.""
*
Figure* 4:* LV* mediated* expression* of* IL713* in* the* splenium* protects* locally* against* cuprizone7
induced*inflammation,*oligodendrocyte*death*and*demyelination."
Panel" a" shows" a" representative" T2" map" for" each" experimental" group" at" the" level" of" the" external"
capsule." Hyper=intense" contrast" can" be" visualized" at" the" level" of" the" external" capsule," reflecting"
inflammation"and/or"demyelination."Scale"bar"="1"mm."T2"values"of" individual"mice"are"displayed"in"
the"graph"with"mean±"SD"and"reveal"an"increase"of"T2"value"in"all"cuprizone"treated"mice"at"the"level"
of"the"external"capsule"(n"="5=14"mice)."***P<0.001,"Linear"mixed"model","Tukey"post"hoc"test."All"p=
values" –" whether" or" not" significant" =" are" indicated" in" the" Supplementary" Table" S8." In" a" similar"
manner,"panel"b"shows"a"representative"color=coded"MTR"image"for"each"experimental"group"at"the"
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level"of"the"external"capsule."Disappearance"of"the"contrast"from"the"external"capsule"(color=coded"
with" red)" can" be" visualized" in" groups" that" received" the" cuprizone" supplemented" diet," reflecting"
inflammation"and/or"demyelination."Scale"bar"="1"mm."MTR"of" individual"mice"are"displayed" in"the"
graph" with" mean" ±" SD" and" indicated" a" decrease" of" MTR" in" all" cuprizone" treated" mice." *P<0.05,"
***P<0.001,"Linear"regression"model,"Tukey"post"hoc"test."(n"="5=11"mice)."All"p=values"–"whether"or"
not"significant"="are"indicated"in"the"Supplementary"Table"S9."Histological"analyses"performed"at"the"
level" of" the" external" capsule" for" CC1+" oligodendrocytes," MBP" myelination," F4/80+" activated"
microglia/macrophages"and"GFAP+"astrogliosis"are"depicted"in"panels"c,"d,"e"and"f,"respectively,"and"
confirm" oligodendrocytes" cell" loss" and" demyelination" associated"with" the" presence" of"microgliosis"
and"astrogliosis"and"in"all"cuprizone"treated"mice"at"the"level"of"the"external"capsule,"independently"
of"LV"injection"(n"="3=5"mice)."Scale"bar"="100"μm."
"
Figure*5:*LV*mediated*expression*of*IL713*in*the*splenium*alters*phenotypic*properties*of*activated*
F4/80+*microglia/macrophages*during*cuprizone*treatment.*
Phenotypic"properties"of"microglia/macrophages"at"the"level"of"the"splenium"of"the"CC"was"assessed"
after" injection"of"LV"followed"by"four"weeks"of"cuprizone"administration."(a)"Representative" images"
of"each"experimental" group" stained" for" F4/80" (red)"and"MHC=II" (green)." Scale"bar"=100"μm."Graph"
displays"MHCII" staining" expressed" as" percentage" relative" of" F4/80+" cells" of" non=injected" cuprizone"
treated"mice"±"SEM."Downward"error"bars"for"white"coded"bars."Upward"error"bars"for"black"coded"
bars." Significant"appearance"of"MHCII" expression" is" indicated"by" the"*" sign."**P<0.01,"***P<0.001,"
One" sample" t=test" (n=" 3=6" mice)." All" p=values" –" whether" or" not" significant" =" are" indicated" in"
Supplementary"Table"S10." (b)"Representative" images"of"each"experimental"group"stained" for"F4/80"
(red)"and"Arg=1" (green)."Scale"bar"=100"μm."Graph"displays"Arg=1"staining"expressed"as"percentage"
relative"of"F4/80+"cells"of"non=injected"cuprizone"treated"mice"±"SEM."Downward"error"bars"for"white"
coded"bars."Upward" error" bars" for" black" coded"bars." Significant" appearance"of"Arg=1" expression" is"
indicated" by" the" #" sign." #P<0.05," One" sample" t=test" (n=" 3=6" mice)." All" p=values" –" whether" or" not"
39"
"
significant" =" are" indicated" in" Supplementary" Table" S11." (c)" Representative" images" of" each"
experimental"group"stained"for"Arg=1"(red)"and"MHCII"(green)."Scale"bar"=100"μm."Graph"shows"the"
density"of"Arg=1+" and"MHCII+" cells" ±" SEM." Significant" appearance"of"MHCII,"Arg=1" and"MHCII/Arg=1"
expression"is"indicated"by"the"*,"#"and"◊"symbols,"respectively."*/#/◊"P<0.05,"**P<0.01,"One"sample"
t=test"(n="3–6"mice)."All"p=values"–"whether"or"not"significant"="are"indicated"in"Supplementary"Table"
S12."
"
Figure* 6:* LV* mediated* expression* of* IL713* in* the* splenium* induces* a* unique* phenotypic* and*
cytokine*profile*during*cuprizone*treatment.*
Graphs"show"the"mRNA"expression"of"cytokines"and"phenotypic"markers"at"the"level"of"the"CC"after"
injection"of"LV"followed"by"four"weeks"of"cuprizone"supplemented"diet"for"(a)"Arg=1,"Arginase=1;"(b)"
YM=1,"chitinase=like"3;"(c)"Gal=3,"galectin=3;"(d)"TNF=α,"tumor"necrosis"factor"α;"(e)" IL=1β," interleukin"
1β;" (f)" iNOS," inducible" nitric" oxide" synthase." Values" are" expressed" as" fold" versus" control" (No" inj."
CONTROL)"±"SEM."*P<0.05,"**P<0.01,"***P<0.001,"One=way"ANOVA,"Dunnett’s"multiple"comparison"
test"(n="7=10"mice)."All"p=values"–"whether"or"not"significant"="are"indicated"in"Supplementary"Table"
S13."
"
Figure*7:*Both*microglia*and*macrophage*phenotype*is*modulated*through*LV*mediated*expression*
of*IL713*in*the*splenium.***
(a)" eGFP+" bone" marrow" chimeric" mice" were" generated" in" order" to" differentiate" infiltrating"
macrophages"(green)"from"brain=resident"microglia."At"eight"week"of"age"mice"received"an"injection"
of"BFP"LV,"IL=13"LV"or"no"injection"(No"inj.)"and"were"fed"a"cuprizone"diet"for"a"period"of"four"weeks"
to" induce" inflammation" and" demyelination." (b)" Representative" T2=weighted" images" show" hyper=
intense" contrast" at" the" level" of" the" splenium" of" the" CC" indicative" of" neuro=inflammation" and"
demyelination"following"four"weeks"of"cuprizone"diet,"but"not"in"the"case"of"mice"that"also"received"
the" IL=13" LV" injection" (Arrow" indicates" the" site" of" injection" of" IL=13" LV" and" associated" protection"
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against" cuprizone)." (c)"Representative" images"of" each"experimental" group" stained" for"MHCII" (blue)"
and"Arg=1"(red)."Scale"bar"="100"μm."(d)"Graph"shows"the"mean"density"±"RMSD"(root"mean"square"
deviation)" of" eGFP+" infiltrating" macrophages" into" the" splenium." *P<0.05," Generalized" estimating"
equations"and"Bonferroni"post"hoc"test"(n"="3"mice)."All"p=values"–"whether"or"not"significant"=" "are"
indicated"in"Supplementary"Table"S14."(d)"Graph"shows"the"mean"density"±"RMSD"of"Arg=1"and"MHCII"
cells."Significant"appearance"of"MHCII+,"Arg=1+"and"MHCII/Arg=1+"expressing"cells"is"indicated"by"the"*,"
#"and"◊"symbols,"respectively."*/#/◊"P<0.05,"**P<0.01,"◊◊◊P<0.001,"Generalized"estimating"equation,"
FDR"corrected"(n"="3"mice)."All"p=values"–"whether"or"not"significant"="are"indicated"in"Supplementary"
Table"S15."
*
Figure* 8:* Therapeutic* LV* mediated* expression* of* IL713* in* the* splenium* protects* against* severe*
cuprizone7induced* demyelination* and* is* associated* with* an* altered* microglia/macrophage*
phenotype.*
(a)" Eight" week" old" mice" were" assigned" to" a" control" or" cuprizone" treated" group." In" order" to" test"
whether" IL=13" LV" injection" may" exert" its" protective" effect" during" cuprizone=induced" CNS" neuro=
inflammation"and"demyelination,"a"subgroup"of"mice"that"received"the"cuprizone"diet"for"a"period"of"
2.5"weeks"were" injected"with"the" IL=13"LV."Magnetic"resonance" imaging"evaluation"and"histological"
analysis"were"performed"after"4"weeks"of"cuprizone"administration." (b)"Representative"T2"map"and"
color=coded"MTR"are"shown"for"each"experimental"group"at"the"level"of"the"splenium"of"the"CC."Mice"
that" received" the" cuprizone"diet" and" the" IL=13" LV" injection"after"2.5"weeks"of" cuprizone"diet" show"
preservation"of"the"contrast"characteristic"of"the"CC."Scale"bar"="1"mm."(c)"T2"values"of"individual"mice"
are"displayed"in"the"graph"with"mean"±"SD"and"reveal"a"significant"increase"of"the"normal"T2"for"IL=13"
LV"injected"cuprizone"treated"mice"(n"=""5=15"mice)."**P<0.01,"***P<0.001,"Wilcoxon"rank"sum"test,"
FDR" corrected" (n" =" 5=15" mice)." All" p=values" –" whether" or" not" significant" =" are" indicated" in"
Supplementary" Table" S16." (d)"MTR" of" individuals" are" displayed" in" the" graph"with"mean" ±" SD" and"
reveal" a" lower" deviation"of" the"normal"MTR"of" IL=13" LV" injected" cuprizone" treated"mice" (n" =" 5=15"
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mice)."**P<0.01,"***P<0.001,"Wilcoxon"rank"sum"test,"FDR"corrected"(n"="5=15"mice)."All"p=values"
–" whether" or" not" significant" =" are" indicated" in" Supplementary" Table" S16." (e)" Representative"
fluorescence"images"for"oligodendrocytes"(CC1,"red)"and"myelin"(MBP,"red)"confirm"the"preservation"
of"myelin"in"mice"that"received"the"IL=13"LV"injection"after"2.5"weeks"of"cuprizone"diet."Importantly,"
the"presence"of"Arg=1+"and"MHCII+"cells"at"the"site"of" IL=13LV" injection"was"also"verified"(Arg=1,"red"
and"MHCII,"red),"(n"="3"mice"analyzed"per"group)."Scale"bar"="100"μm."
"











